155 related articles for article (PubMed ID: 36727414)
1. Organizing Pneumonia in A Patient Double-Positive for ANCA and Anti-GBM Antibodies: A Case Report.
Wang FY; Yuan XN; Sun DN; Xiao G; Hu CH; Liao ZH; Ning JP; Xu H; Feng JT; Yin HL; Li XZ
Chin Med Sci J; 2023 Mar; 38(1):66-69. PubMed ID: 36727414
[TBL] [Abstract][Full Text] [Related]
2. Double positivity for antineutrophil cytoplasmic antibody (ANCA) and anti-glomerular basement membrane antibody could predict end-stage renal disease in ANCA-associated vasculitis: a monocentric pilot study.
Yoo BW; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
Clin Rheumatol; 2020 Mar; 39(3):831-840. PubMed ID: 31802348
[TBL] [Abstract][Full Text] [Related]
3. Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients.
McAdoo SP; Tanna A; Hrušková Z; Holm L; Weiner M; Arulkumaran N; Kang A; Satrapová V; Levy J; Ohlsson S; Tesar V; Segelmark M; Pusey CD
Kidney Int; 2017 Sep; 92(3):693-702. PubMed ID: 28506760
[TBL] [Abstract][Full Text] [Related]
4. Anti-glomerular basement membrane disease developing 3 years after the development of Sweet syndrome and 1 year after the development of anti-neutrophil cytoplasmic antibody-associated vasculitis: a case report.
Matsuno S; Itabashi M; Komatsu A; Taito K; Izawa A; Tsuchiya T; Yamanaka N; Oka M; Yumura W; Arai T; Takei T
CEN Case Rep; 2023 Aug; 12(3):259-264. PubMed ID: 36456780
[TBL] [Abstract][Full Text] [Related]
5. An unusual presentation of propylthiouracil-induced anti-MPO and PR3 positive ANCA vasculitis with associated anti-GBM antibodies, IgA nephropathy and an IgG4 interstitial infiltrate: a case report.
Galante JR; Daruwalla CP; Roberts ISD; Haynes R; Storey BC; Bottomley MJ
BMC Nephrol; 2020 Jul; 21(1):295. PubMed ID: 32703233
[TBL] [Abstract][Full Text] [Related]
6. Characteristics and outcome of crescentic glomerulonephritis in patients with both antineutrophil cytoplasmic antibody and anti-glomerular basement membrane antibody.
Srivastava A; Rao GK; Segal PE; Shah M; Geetha D
Clin Rheumatol; 2013 Sep; 32(9):1317-22. PubMed ID: 23624587
[TBL] [Abstract][Full Text] [Related]
7. Renal and overall outcomes of double-positive (ANCA and anti-GBM antibodies) patients compared to ANCA-associated vasculitis patients with severe renal involvement: A multicenter retrospective study with systematic renal pathology analysis.
Clerte M; Philip R; Levi C; Cornec-Le Gall E; Audard V; Huart A; Puéchal X; Touzot M; Rabot N; Thervet É; Aouba A; Karras A
Scand J Rheumatol; 2022 May; 51(3):205-213. PubMed ID: 34169779
[TBL] [Abstract][Full Text] [Related]
8. Impact of anti-glomerular basement membrane antibodies and glomerular neutrophil activation on glomerulonephritis in experimental myeloperoxidase-antineutrophil cytoplasmic antibody vasculitis.
Kanzaki G; Nagasaka S; Higo S; Kajimoto Y; Kanemitsu T; Aoki M; Nagahama K; Natori Y; Tsuboi N; Yokoo T; Shimizu A
Nephrol Dial Transplant; 2016 Apr; 31(4):574-85. PubMed ID: 26582929
[TBL] [Abstract][Full Text] [Related]
9. Possible implication of intermolecular epitope spreading in the production of anti-glomerular basement membrane antibody in anti-neutrophil cytoplasmic antibody-associated vasculitis.
Nishibata Y; Nonokawa M; Tamura Y; Higashi R; Suzuki K; Hayashi H; Masuda S; Nakazawa D; Tanaka S; Tomaru U; Ishizu A
Clin Exp Rheumatol; 2022 May; 40(4):691-704. PubMed ID: 35200124
[TBL] [Abstract][Full Text] [Related]
10. Anti-glomerular basement membrane (anti-GBM) disease accompanied by vasculitis that was not positive for antineutrophil cytoplasmic antibodies to myeloperoxidase and proteinase 3: a report of two cases and the incidence of anti-GBM disease at one institution.
Nakabayashi K; Fujioka Y; Arimura Y; Fukuoka T; Marumo T; Umino M; Kamiya Y; Okai T; Tsurumaki S; Nagasawa T; Yamada A
Clin Exp Nephrol; 2011 Aug; 15(4):504-13. PubMed ID: 21476125
[TBL] [Abstract][Full Text] [Related]
11. Dual myeloperoxidase-antineutrophil cytoplasmic antibody- and antiglomerular basement membrane antibody-positive cases associated with prior pulmonary fibrosis: a report of four cases.
Nakabayashi K; Fujioka Y; Nagasawa T; Kimura T; Kojima K; Arimura Y; Yamada A
Clin Exp Nephrol; 2011 Apr; 15(2):226-34. PubMed ID: 21246240
[TBL] [Abstract][Full Text] [Related]
12. Performance of two strategies for urgent ANCA and anti-GBM analysis in vasculitis.
de Joode AA; Roozendaal C; van der Leij MJ; Bungener LB; Sanders JS; Stegeman CA
Eur J Intern Med; 2014 Feb; 25(2):182-6. PubMed ID: 24361117
[TBL] [Abstract][Full Text] [Related]
13. Clinical features and prognosis of MPO-ANCA and anti-GBM double-seropositive patients.
Hu X; Shen C; Meng T; Ooi JD; Eggenhuizen PJ; Zhou YO; Luo H; Chen JB; Lin W; Gong Y; Xiong Q; Xu J; Liu N; Xiao X; Tang R; Zhong Y
Front Immunol; 2022; 13():991469. PubMed ID: 36389826
[TBL] [Abstract][Full Text] [Related]
14. Atypical anti-glomerular basement membrane disease with anti-GBM antibody negativity and ANCA positivity: a case report.
Guo N; Yin Q; Lei S; He Y; Fu P
BMC Nephrol; 2021 Feb; 22(1):53. PubMed ID: 33546629
[TBL] [Abstract][Full Text] [Related]
15. Anti-hLAMP2-antibodies and dual positivity for anti-GBM and MPO-ANCA in a patient with relapsing pulmonary-renal syndrome.
Etter C; Gaspert A; Regenass S; Wüthrich RP; Kistler T; Kain R; Cohen CD
BMC Nephrol; 2011 Jun; 12():26. PubMed ID: 21651778
[TBL] [Abstract][Full Text] [Related]
16. The Sequential Development of Antiglomerular Basement Membrane Nephritis and Myeloperoxidase-antineutrophil Cytoplasmic Antibody-associated Vasculitis.
Ohashi N; Namikawa A; Ono M; Iwakura T; Isobe S; Tsuji T; Kato A; Yasuda H
Intern Med; 2017 Oct; 56(19):2617-2621. PubMed ID: 28883245
[TBL] [Abstract][Full Text] [Related]
17. A case of anti-neutrophil cytoplasmic antibody-associated vasculitis with anti-glomerular basement membrane antibodies that was successfully treated with mizoribine as a safe and effective remission maintenance therapy with prednisolone and plasma exchange.
Ikeda Y; Fukunari K; Uchiumi S; Awanami Y; Kanaya A; Matsumoto K; Fukuda M; Takashima T; Miyazono M; Ikeda Y
CEN Case Rep; 2020 Feb; 9(1):42-47. PubMed ID: 31612361
[TBL] [Abstract][Full Text] [Related]
18. [ANCA and anti-MBG double-positive vasculitis: An update on the clinical and therapeutic specificities and comparison with the two eponymous vasculitis].
Philip R; Dumont A; Le Mauff B; Martinet M; Martin Silva N; de Boysson H; Lobbedez T; Aouba A; Deshayes S
Rev Med Interne; 2020 Jan; 41(1):21-26. PubMed ID: 31839271
[TBL] [Abstract][Full Text] [Related]
19. [An experience of treatment of double positive myeloperoxidase-antineutrophil cytoplasmic antibodies (MPO-ANCA) and anti-glomerular basement membrane antibodies in Goodpasture's syndrome onset of crescentic glomerulonephritis].
Takeda T; Takeda T; Naiki Y; Yonekawa S; Sakaguchi M; Iwamoto I; Tanaka H; Hasegawa H; Imada A; Kanamaru A; Hiruma S; Maekura S; Hashimoto S; Yamazumi T
Nihon Jinzo Gakkai Shi; 1998 Nov; 40(8):591-6. PubMed ID: 9893458
[TBL] [Abstract][Full Text] [Related]
20. Antigen and epitope specificity of anti-glomerular basement membrane antibodies in patients with goodpasture disease with or without anti-neutrophil cytoplasmic antibodies.
Yang R; Hellmark T; Zhao J; Cui Z; Segelmark M; Zhao MH; Wang HY
J Am Soc Nephrol; 2007 Apr; 18(4):1338-43. PubMed ID: 17329569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
